Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer du foie - TOP -120 des médecins

Pr. agrégé Dr Yusuf Acikgoz apporte son expertise oncologique internationale de l'Ohio State University à l'hôpital universitaire Lokman Hekim d'Ankara.

• Se spécialiser en oncologie médicale avec une formation approfondie
• Participer à des essais cliniques de phase III, notamment les études CheckMate-649 et Fortitude-101
• Être membre de l'American Society of Clinical Oncology (ASCO) et de la Société turque d'oncologie médicale
• Être certifié en bonnes pratiques cliniques et en protection des sujets humains

Le Dr Ozatli se spécialise dans les cancers du sein, du poumon et gastro-intestinaux, traitant les patients à l'hôpital universitaire Istinye Liv.

• Professeur agrégé depuis 2016
• Spécialiste en médecine interne à l'hôpital d'État de Malatya
• Oncologue à la clinique d'oncologie d'Ankara
• Médecin au département d'oncologie de l'hôpital régional de formation et de recherche d'Erzurum

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Spécialisé en chirurgie laparoscopique avancée et oncologique à la Faculté de Médecine Cerrahpaşa de l'Université d'Istanbul.

• Plus de 20 ans d'expérience en chirurgie générale
• Formé en chirurgie bariatrique laparoscopique
• Expertise en chirurgie laparoscopique antireflux

Le professeur associé Nail Paksoy est spécialisé dans le traitement du cancer du foie à l'hôpital Medipol Bahçelievler, avec une vaste expérience en oncologie médicale.

• Certifié par l'ESMO en oncologie médicale
• Participer à de multiples essais cliniques internationaux pour les traitements du cancer
• Publier de nombreux articles de recherche sur divers sujets d'oncologie
• Suivre une formation spécialisée à l'Institut d'oncologie de l'Université d'Istanbul

Le professeur Gül Alco est spécialisé en radio-oncologie pour le cancer du foie à l'hôpital Medipol Acibadem District, avec plus de 20 ans d'expérience.

• Professeur à l'Université Medipol d'Istanbul – une institution médicale de premier plan
• Formation approfondie en radio-oncologie dans les meilleures universités turques
• Membre de la Société turque de radio-oncologie

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Le Dr Alemdar se spécialise dans le traitement du cancer du foie, avec une formation approfondie en oncologie médicale à l'Université d'Akdeniz.

• Certifié en oncologie médicale depuis 2018
• Plus de 15 ans d'expérience en médecine interne et en oncologie
• Travaille au complexe hospitalier Medical Park Antalya

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Le professeur agrégé Babek Tabandeh se spécialise dans la chirurgie du cancer du foie et les techniques mini-invasives à l'hôpital Medical Park Goztepe.

• Plus de 25 ans d'expérience en chirurgie générale
• Membre de la Société de transplantation hépatique
• Auteur de plus de 40 documents médicaux
• Membre du corps professoral de l'Université Bahçeşehir
• Fellow de l'American College of Surgeons

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le Dr Ozden est spécialisé dans le traitement du cancer du foie, avec une formation approfondie en oncologie médicale à l'université de Kocaeli.

• Certifié en médecine interne avec 22 ans d'expérience
• Formé à la faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Membre de l'Association turque d'oncologie médicale

Spécialisée en virothérapie – l'un des domaines les plus récents de l'immunologie – le Dr Jaunalksne apporte des approches innovantes au traitement du cancer du foie à la Clinique Pallas.

• Plus de 30 ans d'expérience en immunologie
• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradiņš
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne

Le Dr Volkan Kinas est spécialiste de la chirurgie du cancer du foie aux hôpitaux Büyük Anadolu, avec une expertise en chirurgies oncologiques et pancréatiques.

• Réaliser des chirurgies des voies biliaires et du cancer de l'estomac
• Effectuer des interventions pour le cancer du côlon et de la thyroïde
• Avoir de l'expérience en chirurgies bariatriques et métaboliques

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.